Ketorolac 30mg/ml for injection is a non-steroidal anti-inflammatory medication (NSAID) used to relieve moderate to severe pain. It is commonly utilised in clinical settings for short-term management of acute pain, particularly after surgical procedures. Indications: Management of moderate to severe acute pain requiring analgesia at the opioid level Postoperative pain relief Musculoskeletal pain management Off-label Uses: Migraine headache treatment Renal colic management Pain associated with sickle cell crisis Acute gouty arthritis Dosage and Administration: Adults: The usual dose is 30 mg via intramuscular (IM) or intravenous (IV) injection every 6 hours as needed, not exceeding 120 mg per day. Elderly, Renal Impairment, and Low Body Weight Patients: Reduce the dose to 15 mg every 6 hours, with a maximum daily dose of 60 mg. Duration: Treatment should not exceed 5 days to minimise the risk of adverse effects. Each box contains five ampoules, with an expiration date of August 2026. This formulation is designed for effective pain management in clinical settings. Note: Ketorolac should be used with caution in patients with a history of gastrointestinal bleeding, renal impairment, or cardiovascular disease.